Company Research Report: 1315 Capital
Company Overview
- Name: 1315 Capital
- Mission: No information is available.
- Founded: No information is available.
- Founder(s): No information is available.
- Key People:
- Adele Oliva named to the 2024 Most Influential Women in Mid-Market M&A
- Headquarters: 2929 Walnut Street, Philadelphia, PA 19104
- Number of Employees: No information is available.
- Revenue: No information is available.
- Known For: Private investment firm with expertise in expansion and growth capital for healthcare services, medical technology, medtech & pharma outsourcing, and health & wellness sectors.
Investment Approach
1315 Capital manages over $1 billion in assets, focusing on healthcare services, medical technologies, and health & wellness. The firm invests in companies positioned to scale rapidly, targeting $10-40 million investments in commercial healthcare businesses with potential revenues of $50-150 million.
Portfolio Highlights
Recent News & Developments
- Primrose Bio Collaboration: Collaborating with Serum Institute of India to develop a novel multi-antigen vaccine.
- SciSafe Acquisition: SciSafe was acquired by 1315 Capital to expand its biostorage solutions as an independent business.
- Experic Investment: Significant growth capital investment to enhance Experic's manufacturing capabilities and expand its global footprint.
Products/Services Analysis
1. SciSafe
- Services Offered: Specialized storage and cold chain management solutions for biopharmaceutical and pharmaceutical companies.
- Key Features: cGMP-compliant, secure, real-time monitored facilities with a focus on regulatory compliance.
2. Experic
- Services Offered: Contract development and manufacturing organization (CDMO) providing services for biopharmaceuticals and pharmaceuticals.
- Key Features: Cutting-edge capabilities, dry powder inhalation (DPI) expertise, customer-centric approach, state-of-the-art cGMP facility.
Recent Developments
Acquisitions and Investments
- SciSafe Acquisition:
- Date: November 14, 2024
- Details: Acquisition from BioLife Solutions, with SciSafe continuing as a standalone entity.
- New Developments: Expansion of biostorage solutions globally.
- Experic Growth Capital Investment:
- Date: October 29, 2024
- Details: Investment to enhance manufacturing capabilities and meet growing demands in the biopharma sector.
Partnerships
- Primrose Bio Partnership:
- Date: January 10, 2025
- Details: Collaboration with Serum Institute of India to develop a novel multi-antigen vaccine.
Other Portfolio Companies
- Aktana: AI-enabled decision support technology for life sciences.
- Biocoat: Hydrophilic coatings for medical device manufacturers.
- Colorescience: Mineral-based skin protection and health solutions.
- Greenbrook TMS: Transcranial magnetic stimulation services for mental health.
This report provides a comprehensive look into 1315 Capital's operational and investment strategies, recent developments, and products offered, focusing on the healthcare investment landscape.
